Wells Fargo’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327K Sell
42,739
-47,985
-53% -$367K ﹤0.01% 4388
2025
Q4
$882K Sell
90,724
-64,656
-42% -$550K ﹤0.01% 4065
2025
Q3
$651K Sell
155,380
-12,625
-8% -$80.7K ﹤0.01% 4106
2025
Q2
$1.56M Buy
168,005
+9,729
+6% +$84.9K ﹤0.01% 3401
2025
Q1
$1.54M Buy
158,276
+80,905
+105% +$1M ﹤0.01% 3368
2024
Q4
$937K Buy
77,371
+39,121
+102% +$475K ﹤0.01% 3757
2024
Q3
$419K Buy
38,250
+8,449
+28% +$85.8K ﹤0.01% 4110
2024
Q2
$268K Buy
29,801
+3,403
+13% +$23.7K ﹤0.01% 4317
2024
Q1
$216K Buy
26,398
+4,009
+18% +$32.9K ﹤0.01% 4426
2023
Q4
$189K Sell
22,389
-23,168
-51% -$269K ﹤0.01% 4496
2023
Q3
$779K Buy
45,557
+5,608
+14% +$110K ﹤0.01% 3497
2023
Q2
$928K Sell
39,949
-4,384
-10% -$85.7K ﹤0.01% 3526
2023
Q1
$783K Buy
44,333
+44,254
+56,018% +$1.05M ﹤0.01% 3549
2022
Q4
$2.15K Sell
79
-438
-85% -$9.1K ﹤0.01% 6001
2022
Q3
$9K Sell
517
-443
-46% -$8.45K ﹤0.01% 5734
2022
Q2
$17K Sell
960
-1,631
-63% -$26.8K ﹤0.01% 5531
2022
Q1
$44K Sell
2,591
-10,098
-80% -$191K ﹤0.01% 5721
2021
Q4
$343K Buy
12,689
+12,661
+45,218% +$379K ﹤0.01% 4959
2021
Q3
$1K Hold
28
﹤0.01% 6778
2021
Q2
$1K Sell
28
-27,008
-100% -$924K ﹤0.01% 6720
2021
Q1
$825K Sell
27,036
-18,551
-41% -$695K ﹤0.01% 4377
2020
Q4
$1.74M Buy
45,587
+31,813
+231% +$1.33M ﹤0.01% 3603
2020
Q3
$317K Sell
13,774
-3,657
-21% -$83.3K ﹤0.01% 4676
2020
Q2
$433K Buy
17,431
+8,471
+95% +$150K ﹤0.01% 4430
2020
Q1
$89K Sell
8,960
-9,327
-51% -$139K ﹤0.01% 5119
2019
Q4
$262K Sell
18,287
-7,057
-28% -$102K ﹤0.01% 4802
2019
Q3
$352K Buy
25,344
+2,254
+10% +$27.7K ﹤0.01% 4609
2019
Q2
$338K Buy
23,090
+15,672
+211% +$227K ﹤0.01% 4646
2019
Q1
$113K Sell
7,418
-3,007
-29% -$37.5K ﹤0.01% 5093
2018
Q4
$104K Buy
10,425
+9,368
+886% +$127K ﹤0.01% 5261
2018
Q3
$17K Buy
+1,057
New +$18.5K ﹤0.01% 5869

Other funds holding REPL

Wells Fargo's REPL Position: Q1 2026 in Review

Wells Fargo reduced its Replimune Group (REPL) stake by 53% in Q1 2026, selling an estimated $367K and leaving 42,739 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Wells Fargo first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.74M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Wells Fargo held 42,739 shares of Replimune Group worth $327K as of Q1 2026.
  • Wells Fargo sold 47,985 Replimune Group shares in Q1 2026, an estimated $367K.
  • Replimune Group made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4388 holding.
  • Wells Fargo first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Wells Fargo's Replimune Group position peaked at $1.74M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.